CN104667193B - A kind of Chinese medicine composition for treating purpura disease - Google Patents
A kind of Chinese medicine composition for treating purpura disease Download PDFInfo
- Publication number
- CN104667193B CN104667193B CN201510124625.3A CN201510124625A CN104667193B CN 104667193 B CN104667193 B CN 104667193B CN 201510124625 A CN201510124625 A CN 201510124625A CN 104667193 B CN104667193 B CN 104667193B
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine composition
- chinese medicine
- radix
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to technical field of traditional Chinese medicines.The purpose of the present invention is the understanding mechanism according to the traditional Chinese medical science to one disease of purpura, and then a kind of Chinese medicine composition for treating the disease is provided, which be composed using the material medicine of following weight proportion：5 15 parts of Rhizoma Atractylodis Macrocephalae, 10 20 parts of the radix paeoniae rubrathe, 39 parts of Radix Glycyrrhizae, 5 15 parts of rheum officinale, 10 20 parts of glutinous rehmannia, 10 20 parts of fritillaria, 15 25 parts of Radix Salviae Miltiorrhizae, 10 20 parts of Radix Curcumae, 5 15 parts of the root of three-nerved spicebush, 10 20 parts of the fruit of glossy privet, 9 15 parts of peach kernel, 5 15 parts of Fructus Aurantii, 15 25 parts of motherwort, 10 20 parts of safflower, 10 20 parts of sargentodoxa cuneata, 9 15 parts of cassia twig, 5 15 parts of moutan bark, 10 20 parts of cortex albiziae, 15 25 parts of Cortex Phellodendri, 20 30 parts of Chinese ephedra, 25 35 parts of gypsum.Although the Chinese medicine composition is common drug on choice of drug, by the accurate dialectical Analyses of illness, conventional medicine being carried out reasonable compatibility, dosage is considered, satisfactory therapeutic effect can be obtained.
Description
Technical field
The invention belongs to technical field of traditional Chinese medicines, in particular to a kind of Chinese medicine compositions for treating purpura disease.
Background technology
Purpura, also known as purple plague purpura, are overflow with blood under skin, mucous membrane, petechia ecchymosis occur, and pressure is not faded for its clinic
Feature is one of common hemorrhagic disease of children.Often with nosebleed epistaxis, bleeding from the gum, very then spitting blood, have blood in stool, hematuria.This disease belongs to blood trouble model
Farmland, the diseases such as recorded " ecchynosis ", " flesh nosebleed ", " spot is malicious ", have similarity with this disease in Chinese medical book.This disease includes west
The anaphylactoid purpura and thrombocytopenic purpura of medicine.
The content of the invention
The purpose of the present invention is the understanding mechanism according to the traditional Chinese medical science to one disease of purpura, and then provide a kind of Chinese medicine for treating the disease
Composition.
To realize above-mentioned technical purpose, the technical solution adopted by the present invention is：A kind of Chinese medicine composition for treating purpura disease,
It is characterized in that, the Chinese medicine composition is composed using the material medicine of following weight proportion：5-15 parts of Rhizoma Atractylodis Macrocephalae, the radix paeoniae rubrathe
10-20 parts, 3-9 parts of Radix Glycyrrhizae, 5-15 parts of rheum officinale, 10-20 parts of glutinous rehmannia, 10-20 parts of fritillaria, 15-25 parts of Radix Salviae Miltiorrhizae, 10-20 parts of Radix Curcumae,
5-15 parts of the root of three-nerved spicebush, 10-20 parts of the fruit of glossy privet, 9-15 parts of peach kernel, 5-15 parts of Fructus Aurantii, 15-25 parts of motherwort, 10-20 parts of safflower, big blood
10-20 parts of rattan, 9-15 parts of cassia twig, 5-15 parts of moutan bark, 10-20 parts of cortex albiziae, 15-25 parts of Cortex Phellodendri, 20-30 parts of Chinese ephedra, gypsum
25-35 parts.
The best weight ratio of above-mentioned raw materials drug is：10 parts of Rhizoma Atractylodis Macrocephalae, 15 parts of the radix paeoniae rubrathe, 6 parts of Radix Glycyrrhizae, 10 parts of rheum officinale, glutinous rehmannia
15 parts, 15 parts of fritillaria, 20 parts of Radix Salviae Miltiorrhizae, 15 parts of Radix Curcumae, 12 parts of the root of three-nerved spicebush, 15 parts of the fruit of glossy privet, 12 parts of peach kernel, 10 parts of Fructus Aurantii, motherwort
20 parts, 15 parts of safflower, 15 parts of sargentodoxa cuneata, 12 parts of cassia twig, 10 parts of moutan bark, 15 parts of cortex albiziae, 20 parts of Cortex Phellodendri, 25 parts of Chinese ephedra, stone
30 parts of cream.
The instructions of taking of Chinese medicine composition provided by the present invention is：It is adopted after the material medicine of above-mentioned weight proportion is mixed
Its concoction 300-500ml is taken with the method for conventional fried Chinese medicine, is taken twice daily morning and evening, daily one is secondary.
Prescription analysis：《Surgery is authentic》In point out that the disease is joined the army by heat symptoms caused by an exopathgen, muscle, space between skin and muscles point burnt by it burn and outgoing in
Skin, spot color are livid purple.It is more common in child and teenager.Clear Shao Xian points out " heat is accumulate in stomach, injures blood the moon " for its main pathogenesis.
That controls works as the heresy for going its sun bright, and the heat of its clear blood system makes poison not enemy intrusion or invasion；Gas in beneficial blood, enables gas to lead blood, and gas row poisons.”
Accordingly, in Chinese medicine composition provided by the present invention, gypsum, rheum officinale are taken with the bright heat symptoms caused by an exopathgen of sun of going out, stomach energy heresy is gone
Then cloudy blood is not hindered；The radix paeoniae rubrathe, glutinous rehmannia, the fruit of glossy privet, sargentodoxa cuneata, Radix Curcumae, moutan bark clearing heat and cooling blood are taken, heat goes then business revenue, and blood is not excessive.
With the disease of purple plague purpura, disease of now becoming silted up takes Radix Salviae Miltiorrhizae, peach kernel, safflower, motherwort, cortex albiziae invigorate blood circulation.Gas is because of lung, the dryness of the lung simultaneously
Then gas heat, defends the shape of gas not smooth then existing " nosebleed epistaxis " " nose ring ", therefore often goes out while one onset of purple plague purpura with diseases such as nosebleed epistaxis, bleeding from the gum
It is existing, therefore in Chinese medicine composition provided by the present invention, fritillaria, Cortex Phellodendri is taken to let out its lung heat.But one disease of purple plague purpura always because of natural endowment not
Resistance to, heat evil damage train of thought, heat evil is fade-in, and the people of the overabundance of yang then shows internal organs intrinsic heat, therefore is removed during treatment one disease of purple plague purpura and use above-mentioned medicine
More it should be noted that exopathogen is driven outside the bright heat symptoms caused by an exopathgen of the clear sun of object, clearing heat and cooling blood promoting menstruation.In the Chinese medicine composition, cassia twig, root of three-nerved spicebush temperature are taken
Through promoting blood circulation, the big loosing the interspaces of skin and muscles of Chinese ephedra compels heresy and goes out, and heat symptoms caused by an exopathgen go out, and battalion defends and seeks Wei Buyu, with smooth, purple plague purpura self solves qi and blood.Therefore take
After the Chinese medicine composition, often now sweating as, it should be understood that then heresy goes out for sweating, and with the people of the overabundance of yang can to the greatest extent send out its sweat, must not hinder
Just.It is subject to appropriate Rhizoma Atractylodis Macrocephalae, Fructus Aurantii, Radix Glycyrrhizae in prescription with admittedly middle coke, there is the benefits of reinvigoration.The Chinese medicine composition is in choice of drug
Although upper for common drug, by the accurate dialectical Analyses of illness, conventional medicine being carried out reasonable compatibility, considers dosage,
It can obtain satisfactory therapeutic effect.
Specific embodiment
With reference to embodiment, the present invention will be further described.
Embodiment 1
A kind of Chinese medicine composition for treating purpura disease, which is characterized in that the Chinese medicine composition is using following weight proportion
Material medicine be composed：It is Rhizoma Atractylodis Macrocephalae 10g, radix paeoniae rubrathe 15g, Radix Glycyrrhizae 6g, rheum officinale 10g, glutinous rehmannia 15g, fritillaria 15g, Radix Salviae Miltiorrhizae 20g, strongly fragrant
Golden 15g, root of three-nerved spicebush 12g, fruit of glossy privet 15g, peach kernel 12g, Fructus Aurantii 10g, motherwort 20g, safflower 15g, sargentodoxa cuneata 15g, cassia twig 12g,
Moutan bark 10g, cortex albiziae 15g, Cortex Phellodendri 20g, Chinese ephedra 25g, gypsum 30g.
In the present embodiment, clinical test has been carried out using the material medicine of above-mentioned weight proportion, experiment is as follows：
Purple plague purpura patient 62 is accepted for medical treatment since 2012, the age is especially in the majority with children based on 5-20 Sui, Symptoms
For：There is position based on double lower limb in purpura, and ecchymosis or petechia differ in size, and are unevenly distributed, and is not higher by surface, and that presses is colour-fast
Also not pain.Most of patient purpura occur occurring early period fever, headache, it is weak, receive the symptoms such as difference.It understands accordingly, exopathogen
The main predisposing factors for purpura are inside invaded, patient is young and aggressive, and yang-energy is sufficient, and same gas is invaded in exopathogen into internal organs heat, purpura to be caused to go out
It is existing.The Chinese medicine composition provided in the embodiment, 7 days as one therapeutic course are taken in therapeutic scheme selection.
Treatment standard
1st, purpura area reduce or color it is thin out be effective.
2nd, purpura disappears, and the diseases caused by external factors symptom such as headache, fever disappears to cure.
Effect is as follows：
In 62 patients, wherein there are 41 patients to show within 1-2 days curative effect taking, the diseases caused by external factors symptom such as fever, headache
Mitigate, purpura lighter, partial portion purpura disappears, and continues to take after the drug amounts to 1 course for the treatment of, 39 patient purpuras are complete
It disappears, diseases caused by external factors symptom loses, and one disease of purpura is fully recovered.Remaining 13 patients continued to take the Chinese medicine composition after 1 week, there is 6
Example recovery from illness, remaining 7 symptoms are alleviated, but do not fully recover.By above-mentioned clinical test, the Chinese medicine composition is purple in treatment
On one disease of purplish or white patches on the skin, therapeutic effect performance is outstanding.
Embodiment 2
A kind of Chinese medicine composition for treating purpura disease, which is characterized in that the Chinese medicine composition is using following weight proportion
Material medicine be composed：Rhizoma Atractylodis Macrocephalae 5g, radix paeoniae rubrathe 20g, Radix Glycyrrhizae 9g, rheum officinale 15g, glutinous rehmannia 10g, fritillaria 20g, Radix Salviae Miltiorrhizae 15g, Radix Curcumae
20g parts, it is root of three-nerved spicebush 5g, fruit of glossy privet 10g, peach kernel 15g, Fructus Aurantii 5g, motherwort 15g, safflower 20g, sargentodoxa cuneata 10g, cassia twig 15g, male
Root bark of tree peony 5g, cortex albiziae 10g, Cortex Phellodendri 25g, Chinese ephedra 30g, gypsum 35g.
Model case
Man, 12 years old, there is symmetry purple plague purpura spot in lower limb when medical, and area accounts for skin of lower extremity more than 30%, spot diameter
1-3cm.Have headache, heating paresthesia, 37.5 DEG C of body temperature when medical concurrently.
After taking 3 pair of Chinese medicine composition provided in the present embodiment, purple plague purpura disappears, and headache, heating paresthesia lose, and body temperature is extensive
It is multiple normal.
Embodiment 3
A kind of Chinese medicine composition for treating purpura disease, which is characterized in that the Chinese medicine composition is using following weight proportion
Material medicine be composed：Rhizoma Atractylodis Macrocephalae 15g, radix paeoniae rubrathe 10g, Radix Glycyrrhizae 3g, rheum officinale 5g, glutinous rehmannia 20g, fritillaria 10g, Radix Salviae Miltiorrhizae 25g, Radix Curcumae
10g, root of three-nerved spicebush 15g, fruit of glossy privet 20g, peach kernel 9g, Fructus Aurantii 15g, motherwort 25g, safflower 10g, sargentodoxa cuneata 20g, cassia twig 9g, tree peony
Skin 15g, cortex albiziae 20g, Cortex Phellodendri 15g, Chinese ephedra 20g, gypsum 25g.
Model case
Female, 22 years old, there is the purple plague purpura least bit, spot diameter 2-5cm in four limbs and chest when medical, and speck area accounts for skin surface
Product more than 50%, superficial and rapid pulse, right Guan pulse are big, the diseases caused by external factors symptom such as no fever, headache.
After taking 7 pair of Chinese medicine composition provided in the present embodiment, purple plague purpura disappears, away from modern half a year again without recurrence.
Embodiment 4
A kind of Chinese medicine composition for treating purpura disease, which is characterized in that the Chinese medicine composition is using following weight proportion
Material medicine be composed：5 parts of Rhizoma Atractylodis Macrocephalae, 20 parts of the radix paeoniae rubrathe, 3 parts of Radix Glycyrrhizae, 15 parts of rheum officinale, 10 parts of glutinous rehmannia, 20 parts of fritillaria, Radix Salviae Miltiorrhizae 15
Part, 20 parts of Radix Curcumae, 5 parts of the root of three-nerved spicebush, 20 parts of the fruit of glossy privet, 9 parts of peach kernel, 15 parts of Fructus Aurantii, 15 parts of motherwort, 20 parts of safflower, sargentodoxa cuneata 10
Part, 15 parts of cassia twig, 5 parts of moutan bark, 20 parts of cortex albiziae, 15 parts of Cortex Phellodendri, 30 parts of Chinese ephedra, 25 parts of gypsum.
Embodiment 5
A kind of Chinese medicine composition for treating purpura disease, which is characterized in that the Chinese medicine composition is using following weight proportion
Material medicine be composed：15 parts of Rhizoma Atractylodis Macrocephalae, 10 parts of the radix paeoniae rubrathe, 9 parts of Radix Glycyrrhizae, 5 parts of rheum officinale, 20 parts of glutinous rehmannia, 10 parts of fritillaria, Radix Salviae Miltiorrhizae 25
Part, 10 parts of Radix Curcumae, 15 parts of the root of three-nerved spicebush, 10 parts of the fruit of glossy privet, 15 parts of peach kernel, 5 parts of Fructus Aurantii, 25 parts of motherwort, 10 parts of safflower, sargentodoxa cuneata 20
Part, 9 parts of cassia twig, 15 parts of moutan bark, 10 parts of cortex albiziae, 25 parts of Cortex Phellodendri, 20 parts of Chinese ephedra, 35 parts of gypsum.
Claims (1)
1. a kind of Chinese medicine composition for treating purpura disease, which is characterized in that the Chinese medicine composition is using following weight proportion
Material medicine is composed：10 parts of Rhizoma Atractylodis Macrocephalae, 15 parts of the radix paeoniae rubrathe, 6 parts of Radix Glycyrrhizae, 10 parts of rheum officinale, 15 parts of glutinous rehmannia, 15 parts of fritillaria, Radix Salviae Miltiorrhizae 20
Part, 15 parts of Radix Curcumae, 12 parts of the root of three-nerved spicebush, 15 parts of the fruit of glossy privet, 12 parts of peach kernel, 10 parts of Fructus Aurantii, 20 parts of motherwort, 15 parts of safflower, sargentodoxa cuneata
15 parts, 12 parts of cassia twig, 10 parts of moutan bark, 15 parts of cortex albiziae, 20 parts of Cortex Phellodendri, 25 parts of Chinese ephedra, 30 parts of gypsum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510124625.3A CN104667193B (en) | 2015-03-23 | 2015-03-23 | A kind of Chinese medicine composition for treating purpura disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510124625.3A CN104667193B (en) | 2015-03-23 | 2015-03-23 | A kind of Chinese medicine composition for treating purpura disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104667193A CN104667193A (en) | 2015-06-03 |
| CN104667193B true CN104667193B (en) | 2018-05-29 |
Family
ID=53303129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510124625.3A Expired - Fee Related CN104667193B (en) | 2015-03-23 | 2015-03-23 | A kind of Chinese medicine composition for treating purpura disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104667193B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101623450A (en) * | 2008-07-08 | 2010-01-13 | 董云 | Decocted Chinese medicinal composition for treating allergic purpura |
-
2015
- 2015-03-23 CN CN201510124625.3A patent/CN104667193B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101623450A (en) * | 2008-07-08 | 2010-01-13 | 董云 | Decocted Chinese medicinal composition for treating allergic purpura |
Non-Patent Citations (1)
| Title |
|---|
| 王烈教授对小儿紫癜的证治经验;冯晓纯;《吉林中医药》;19940520(第3期);第4-5页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104667193A (en) | 2015-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102078510B (en) | Chinese medicinal composition for treating coronary heart disease | |
| CN103463500B (en) | Medicament for treating cerebral hemorrhage | |
| CN103223118B (en) | Traditional Chinese medicine composition for treating facial paralysis | |
| CN103341049A (en) | Dendrobium huoshanense-containing traditional Chinese medicine composition with anti-fatigue effect, and preparation method thereof | |
| CN102406808A (en) | Traditional Chinese medicine composition for treating thoracic obstruction | |
| CN102048939B (en) | Medicament for treating sinus bradycardia | |
| CN102988892B (en) | Medicament for treating hysteromyoma and ovarian cysts | |
| CN104667193B (en) | A kind of Chinese medicine composition for treating purpura disease | |
| CN104667249B (en) | A kind of Chinese medicine composition for treating primary dysmenorrhea | |
| CN103083632B (en) | Traditional Chinese medicine for treating recurrent aphthae | |
| CN104645207A (en) | Traditional Chinese medicine composition for treating angina | |
| CN100363037C (en) | Medicine for treating rheumarthritis and traumatic injury pain and its prpen | |
| CN100998689B (en) | Traditional Chinese medicine preparation for treating chronic nephritis, kidney failure | |
| CN103933269A (en) | Traditional Chinese medicine for treating metrorrhagia disease | |
| CN103948880B (en) | Traditional Chinese medicine for treating arrhythmia | |
| CN104667019B (en) | It is a kind of treat diseases caused by external factors caused by purpura disease Chinese medicine composition | |
| CN102961682B (en) | Traditional Chinese medicine composition for clearing away heat and toxic materials | |
| CN106389598A (en) | Traditional Chinese medicine composition for curing purpura | |
| CN102406913A (en) | Chinese medicinal composition for treating melancholia | |
| CN104352773A (en) | Traditional Chinese medicine preparation for treating chronic bronchitis and bronchial asthma | |
| CN103495022A (en) | Traditional Chinese medicine for adjuvant therapy of aids | |
| CN103520468B (en) | A kind of Chinese medicine for the treatment of viral myocarditis | |
| CN102908438A (en) | Kidney invigorating, essence strengthening, qi reinforcing, blood nourishing and body immunity improving capsules | |
| CN102772665A (en) | Traditional Chinese medicine preparation for treating yin deficiency and internal heat type vital myocarditis and preparation method thereof | |
| CN102283963A (en) | Traditional Chinese medicine composition for curing peptic ulcer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information |
Inventor after: Chen Fang Inventor before: Jiang Fengxia |
|
| CB03 | Change of inventor or designer information | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20180425 Address after: 262500 room 4, unit 4, crystal street, Qingzhou, Shandong, 501. Applicant after: Chen Fang Address before: 264300 Liming North Road, Rongcheng City, Weihai, Shandong Applicant before: Jiang Fengxia |
|
| TA01 | Transfer of patent application right | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180529 Termination date: 20190323 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |